Curaleaf Holdings (CURLF) EPS (Basic) (2019 - 2026)
Curaleaf Holdings (CURLF) recorded quarterly EPS (Basic) of -$3255.6 in Q1 2026, down 29878.61% quarter-over-quarter from -$10.86 in Q4 2025, and down 23791324.24% on a YoY basis from N/an in Q1 2025.
Curaleaf Holdings (CURLF) EPS (Basic) (2019 - 2026) Analysis & Trends
Curaleaf Holdings' EPS (Basic) history runs 8 years deep, the most recent figure standing at -$3255.6 for Q1 2026.
- In Q1 2026, EPS (Basic) fell 23791324.24% year-over-year to -$3255.6; the TTM figure through Mar 2026 stood at -$3270.4 (down 11479030.85% YoY), while the FY2025 annual figure was -$0.35, down 12.9% from the prior year.
- EPS (Basic) was -$3255.6 for Q1 2026 at Curaleaf Holdings, down from -$10.86 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.03 in Q1 2022 to a low of -$3255.6 in Q1 2026.
- Historically, EPS (Basic) has averaged -$234.39 across 5 years, with a median of -$0.01 in 2024.
- The sharpest annual moves came in 2024 and 2026: EPS (Basic) jumped 106.11% in 2024, then sank 23791324.24% in 2026.
- A 5-year view of EPS (Basic) shows it stood at -$0.02 in 2022, then slumped by 61433.47% to -$11.04 in 2023, then jumped by 99.86% to -$0.02 in 2024, then slumped by 71044.87% to -$10.86 in 2025, then slumped by 29878.61% to -$3255.6 in 2026.
- The last three EPS (Basic) figures came in at -$3255.6 (Q1 2026), -$10.86 (Q4 2025), and -$3.97 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 0.32 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 1.42 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 6.32 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 0.02 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1.97 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 0.11 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -0.40 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -0.40 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.83 |
| 10 | Curaleaf Holdings | - | - | 157.29 Mn | -3,255.56 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,255.56 |
| Dec 31, 2025 | -10.86 |
| Jun 30, 2025 | -3.97 |
| Mar 31, 2025 | -0.01 |
| Dec 31, 2024 | -0.02 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | -11.04 |
| Sep 30, 2023 | -0.04 |
| Jun 30, 2023 | -0.01 |
| Sep 30, 2022 | -0.02 |
| Jun 30, 2022 | -0.01 |
| Mar 31, 2022 | 0.03 |
| Dec 31, 2021 | 0.00 |
| Sep 30, 2021 | 0.09 |
| Jun 30, 2021 | 0.11 |
| Mar 31, 2021 | 0.07 |
| Dec 31, 2020 | 0.03 |
| Sep 30, 2020 | 0.02 |